High expression of GREM1 promotes the growth and proliferation of tumor cells in breast cancer and glioma [20, 30], but inhibits the development of tumors in osteosarcoma and pancreatic ductal adenocarcinoma [21, 22]. This evidence concerns the gene GREM1 and central nervous system cancer.